Skip to main content
Bohn Stafleu van Loghum
ZOEKEN
MENU 1 2 3 4
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 9/2020

07-04-2020

Parental health spillover effects of paediatric rare genetic conditions

Auteurs: You Wu, Hareth Al-Janabi, Andrew Mallett, Catherine Quinlan, Ingrid E. Scheffer, Katherine B. Howell, John Christodoulou, Richard J. Leventer, Paul J. Lockhart, Zornitza Stark, Tiffany Boughtwood, Ilias Goranitis

Gepubliceerd in: Quality of Life Research | Uitgave 9/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

The complexity and severity of rare genetic conditions pose substantial burden to families. While the importance of spillovers on carers’ health in resource allocation decisions is increasingly recognised, there is significant lack of empirical evidence in the context of rare diseases. The objective of this study was to estimate the health spillovers of paediatric rare genetic conditions on parents.

Methods

Health-related quality-of-life (HRQoL) data from children with rare genetic conditions (genetic kidney diseases, mitochondrial diseases, epileptic encephalopathies, brain malformations) and their parents were collected using the CHU9D and SF-12 measures, respectively. We used two approaches to estimate parental health spillovers. To quantify the ‘absolute health spillover’, we matched our parent cohort to the Australian general population. To quantify the ‘relative health spillover’, regression models were applied using the cohort data.

Results

Parents of affected children had significantly lower HRQoL compared to matched parents in the general public (− 0.06; 95% CIs − 0.08, − 0.04). Multivariable regression demonstrated a positive association between parental and child health. The mean magnitude of HRQoL loss in parents was estimated to be 33% of the HRQoL loss observed in children (95% CIs 21%, 46%).

Conclusion

Paediatric rare genetic conditions appear to be associated with substantial parental health spillovers. This highlights the importance of including health effects on family members and caregivers into economic evaluation of genomic technologies and personalised medicine. Overlooking spillover effects may undervalue the benefits of diagnosis and management in this context. This study also expands the knowledge of family spillover to the rare disease spectrum.
vorige artikel Developmental differences in health-related quality of life in adolescent and young adult cancer survivors
volgende artikel The association of socio-economic status, dental anxiety, and behavioral and clinical variables with adolescents’ oral health-related quality of life
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Boycott, K. M., Vanstone, M. R., Bulman, D. E., & MacKenzie, A. E. (2013). Rare-disease genetics in the era of next-generation sequencing: Discovery to translation. Nature Reviews Genetics, 14(10), 681. PubMedCrossRef
2.
3.
Slade, A., Isa, F., Kyte, D., Pankhurst, T., Kerecuk, L., Ferguson, J., et al. (2018). Patient reported outcome measures in rare diseases: A narrative review. Orphanet Journal of Rare Diseases, 13(1), 61. PubMedPubMedCentralCrossRef
4.
Wright, C. F., FitzPatrick, D. R., & Firth, H. V. (2018). Paediatric genomics: Diagnosing rare disease in children. Nature Reviews Genetics, 19(5), 253. PubMedCrossRef
5.
6.
Zurynski, Y., Deverell, M., Dalkeith, T., Johnson, S., Christodoulou, J., Leonard, H., et al. (2017). Australian children living with rare diseases: Experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet Journal of Rare Diseases, 12(1), 68. PubMedPubMedCentralCrossRef
7.
Pelentsov, L. J., Fielder, A. L., Laws, T. A., & Esterman, A. J. (2016). The supportive care needs of parents with a child with a rare disease: Results of an online survey. BMC Family Practice, 17(1), 88. PubMedPubMedCentralCrossRef
8.
Pelentsov, L. J., Laws, T. A., & Esterman, A. J. (2015). The supportive care needs of parents caring for a child with a rare disease: A scoping review. Disability and Health Journal, 8(4), 475–491. PubMedCrossRef
9.
Wittenberg, E., James, L. P., & Prosser, L. A. (2019). Spillover effects on caregivers’ and family members’ utility: A systematic review of the literature. PharmacoEconomics, 37(4), 475–499. PubMedCrossRef
10.
Wittenberg, E., & Prosser, L. A. (2016). Health as a family affair. New England Journal of Medicine, 374(19), 1804–1806. PubMedCrossRef
11.
12.
Sanders, G. D., Neumann, P. J., Basu, A., Brock, D. W., Feeny, D., Krahn, M., et al. (2016). Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second panel on cost-effectiveness in health and medicine. JAMA, 316(10), 1093–1103. PubMedCrossRef
13.
Al-Janabi, H., McLoughlin, C., Oyebode, J., Efstathiou, N., & Calvert, M. (2019). Six mechanisms behind carer wellbeing effects: A qualitative study of healthcare delivery. Social Science & Medicine, 2, 112382. CrossRef
14.
Brouwer, W. B. (2019). The inclusion of spillover effects in economic evaluations: Not an optional extra. PharmacoEconomics, 37(4), 451–456. PubMedCrossRef
15.
Lavelle, T. A., D’Cruz, B. N., Mohit, B., Ungar, W. J., Prosser, L. A., Tsiplova, K., et al. (2019). Family spillover effects in pediatric cost-utility analyses. Applied Health Economics and Health Policy, 17(2), 163–174. PubMedCrossRef
16.
17.
18.
Schwarze, K., Buchanan, J., Taylor, J. C., & Wordsworth, S. (2018). Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genetics in Medicine, 20(10), 1122. PubMedCrossRef
19.
Phillips, K. A., Deverka, P. A., Marshall, D. A., Wordsworth, S., Regier, D. A., Christensen, K. D., et al. (2018). Methodological issues in assessing the economic value of next-generation sequencing tests: Many challenges and not enough solutions. Value in Health, 21(9), 1033–1042. PubMedPubMedCentralCrossRef
20.
Stark, Z., Boughtwood, T., Phillips, P., Christodoulou, J., Hansen, D. P., Braithwaite, J., et al. (2019). Australian genomics: A federated model for integrating genomics into healthcare. The American Journal of Human Genetics, 105(1), 7–14. PubMedCrossRef
21.
22.
Ware, J. E., Kosinski, M., Turner-Bowker, D. M., Gandek, B., QualityMetric, I., New England Medical Center, H., et al. (2002). How to score version 2 of the SF-12 health survey (with a supplement documenting version 1). Lincoln, R.I.; Boston, MA.: QualityMetric Inc. ; Health Assessment Lab.
23.
Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 3, 851–859. CrossRef
24.
Ratcliffe, J., Huynh, E., Chen, G., Stevens, K., Swait, J., Brazier, J., et al. (2016). Valuing the child health utility 9D: Using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm. Social Science & Medicine, 157, 48–59. CrossRef
25.
Stevens, K. (2012). Valuation of the child health utility 9D index. PharmacoEconomics, 30(8), 729–747. PubMedCrossRef
26.
Al-Janabi, H., Van Exel, J., Brouwer, W., Trotter, C., Glennie, L., Hannigan, L., et al. (2016). Measuring health spillovers for economic evaluation: A case study in meningitis. Health Economics, 25(12), 1529–1544. PubMedCrossRef
27.
Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292. PubMedCrossRef
28.
29.
30.
Chen, G., Flynn, T., Stevens, K., Brazier, J., Huynh, E., Sawyer, M., et al. (2015). Assessing the health-related quality of life of Australian adolescents: an empirical comparison of the child health utility 9D and EQ-5D-Y instruments. Value in Health, 18(4), 432–438. PubMedCrossRef
31.
Kwon, J., Kim, S. W., Ungar, W. J., Tsiplova, K., Madan, J., & Petrou, S. (2018). A systematic review and meta-analysis of childhood health utilities. Medical Decision Making, 38(3), 277–305. PubMedCrossRef
32.
33.
Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of Life Research, 14(6), 1523–1532. PubMedCrossRef
34.
Tilford, J. M., Grosse, S. D., Robbins, J. M., Pyne, J. M., Cleves, M. A., & Hobbs, C. A. (2005). Health state preference scores of children with spina bifida and their caregivers. Quality of Life Research, 14(4), 1087–1098. PubMedCrossRef
35.
Hoefman, R. J., van Exel, J., & Brouwer, W. (2013). How to include informal care in economic evaluations. PharmacoEconomics, 31(12), 1105–1119. PubMedCrossRef
36.
Al-Janabi, H., Van Exel, J., Brouwer, W., & Coast, J. (2016). A framework for including family health spillovers in economic evaluation. Medical Decision Making, 36(2), 176–186. PubMedPubMedCentralCrossRef
37.
38.
Brown, C. C., Tilford, J. M., Payakachat, N., Williams, D. K., Kuhlthau, K. A., Pyne, J. M., et al. (2019). Measuring health spillover effects in caregivers of children with autism spectrum disorder: A comparison of the EQ-5D-3L and SF-6D. PharmacoEconomics, 37(4), 609–620. PubMedPubMedCentralCrossRef
39.
40.
Brouwer, W., Van Exel, N., Van Gorp, B., & Redekop, W. (2006). The CarerQol instrument: A new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Quality of Life Research, 15(6), 1005–1021. PubMedCrossRef
41.
Al-Janabi, H., Coast, J., & Flynn, T. N. (2008). What do people value when they provide unpaid care for an older person? A meta-ethnography with interview follow-up. Social Science & Medicine, 67(1), 111–121. CrossRef
42.
Al-Janabi, H., Flynn, T. N., & Coast, J. (2012). Development of a self-report measure of capability wellbeing for adults: The ICECAP-A. Quality of Life Research, 21(1), 167–176. PubMedCrossRef
Metagegevens
Titel
Parental health spillover effects of paediatric rare genetic conditions
Auteurs
You Wu
Hareth Al-Janabi
Andrew Mallett
Catherine Quinlan
Ingrid E. Scheffer
Katherine B. Howell
John Christodoulou
Richard J. Leventer
Paul J. Lockhart
Zornitza Stark
Tiffany Boughtwood
Ilias Goranitis
Publicatiedatum
07-04-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 9/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02497-3

Andere artikelen Uitgave 9/2020

Quality of Life Research 9/2020 Naar de uitgave

OriginalPaper

The association of socio-economic status, dental anxiety, and behavioral and clinical variables with adolescents’ oral health-related quality of life

OriginalPaper

Patient-reported outcomes in maintenance hemodialysis: a cross-sectional, multicenter study

OriginalPaper

Predictive factors of quality of life among systemic lupus erythematosus patients in Thailand: a web-based cross-sectional study

OriginalPaper

Does the EQ-5D usual activities dimension measure what it intends to measure? The relative importance of work, study, housework, family or leisure activities

OriginalPaper

Factors associated with social isolation in community-dwelling older adults: a cross-sectional study

OriginalPaper

Health gap for multimorbidity: comparison of models combining uniconditional health gap